DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Oracea (Doxycycline) - Published Studies

 



Oracea Related Published Studies

Well-designed clinical trials related to Oracea (Doxycycline)

A randomized trial of doxycycline for Mansonella perstans infection. [2009.10.08]

A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. [2009.07]

A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. [2009.06.15]

Supportive periodontal therapy of furcation sites: non-surgical instrumentation with or without topical doxycycline. [2009.06]

Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. [2009.06]

Effects of doxycycline on serum and endometrial levels of MMP-2, MMP-9 and TIMP-1 in women using a levonorgestrel-releasing subcutaneous implant. [2009.06]

Pharmacokinetics of doxycycline in sheep after intravenous and oral administration. [2009.06]

Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. [2009.04.28]

Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content. [2009.03]

Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of doxycycline, co-amoxiclav, and omeprazole in Iranian patients. [2009.03]

Doxycycline serum levels at the time of dilation and evacuation with two dosing regimens. [2009.02]

The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication. [2009.01]

Effects of Ivermectin with and without Doxycycline on Clinical Symptoms of Onchocerciasis. [2009.01]

Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. [2008.12]

Comparative evaluation of subgingivally delivered 10% doxycycline hyclate and xanthan-based chlorhexidine gels in the treatment of chronic periodontitis. [2008.11.01]

Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. [2008.11]

Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. [2008.10]

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. [2008.09]

A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair. [2008.09]

Doxycycline plus levamisole: combination treatment for severe nodulocystic acne. [2008.08]

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. [2008.08]

A randomized, placebo-controlled trial of doxycycline after endoluminal aneurysm repair. [2008.07.14]

Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. [2008.05.01]

Locally delivered doxycycline during supportive periodontal therapy: a 3-year study. [2008.05]

Post-treatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fluid transforming growth factor-beta1 in severe, generalized chronic periodontitis. [2008.05]

Evaluation of the regenerative potential of 25% doxycycline-loaded biodegradable membrane vs biodegradable membrane alone in the treatment of human periodontal infrabony defects: a clinical and radiological study. [2008.04]

The Effect of Adjunctive Subantimicrobial Dose Doxycycline Therapy on GCF EMMPRIN Levels in Chronic Periodontitis. [2008.03]

Modified-Release Subantimicrobial Dose Doxycycline Enhances Scaling and Root Planing in Subjects With Periodontal Disease. [2008.03]

Locally delivered doxycycline as an adjunct to mechanical debridement at retreatment of periodontal pockets. [2008.03]

Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial. [2008.03]

Administration of doxycycline in drinking water for treatment of spiral bacterial infection in cockatiels. [2008.02.01]

Systemic administration of doxycycline versus metronidazole plus amoxicillin in the treatment of localized aggressive periodontitis: a clinical and microbiologic study. [2008.02]

Regeneration of degree ii furcation defects with a 4% doxycycline hyclate bioabsorbable barrier. [2008.01]

Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sjogren's syndrome: a randomized, double-blind, placebo controlled cross-over study. [2007.12.31]

Doxycycline clearance of experimentally induced chronic Ehrlichia canis infection in dogs. [2007.11]

Microbiologic changes following administration of locally delivered doxycycline in smokers: a 15-month follow-up. [2007.11]

Urinary TIINE concentrations in a randomized controlled trial of doxycycline in knee osteoarthritis: implications of the lack of association between TIINE levels and joint space narrowing. [2007.11]

Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women. [2007.09]

Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomes. [2007.09]

Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. [2007.09]

Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea. [2007.09]

Subantimicrobial Dose Doxycycline Effects on Osteopenic Bone Loss: Microbiologic Results. [2007.08]

Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. [2007.08]

Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. [2007.07]

Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. [2007.07]

Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. [2007.06]

Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals. [2007.06]

Controlled Trial of a 5-Day Course of Telithromycin versus Doxycycline for Treatment of Mild to Moderate Scrub Typhus. [2007.06]

Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. [2007.05]

Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: a pilot study. [2007.04]

A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers. [2007.04]

Absence of tooth staining with doxycycline treatment in young children. [2007.03]

Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. [2007.03]

Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. [2007.01.15]

Pharmacokinetic and bioequivalence study of meloxicam tablets in healthy male subjects. [2007]

Comparing 10-day and 4-month doxycycline courses for treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. [2006.11]

Interindividual variability in plasma concentrations after systemic exposure of swine to dietary doxycycline supplied with and without paracetamol: a population pharmacokinetic approach. [2006.11]

Pharmacokinetics of enrofloxacin and its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. [2006.10.28]

Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. [2006.09]

The effect of topical doxycycline usage on gingival crevicular fluid MMP-8 levels of chronic and aggressive periodontitis patients: a pilot study. [2006.08]

Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. [2006.07.13]

A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. [2006.04.15]

Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. [2006.04.15]

Locally delivered doxycycline as an adjunctive therapy to scaling and root planing in the treatment of smokers: a 2-year follow-up. [2006.04]

Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial. [2006.02]

The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction. [2005.12]

Comparison of oral azithromycin pulse with daily doxycycline in the treatment of acne vulgaris. [2003.07]

Well-designed clinical trials possibly related to Oracea (Doxycycline)

A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users. [2009.08]

Clinical assessment of the effect of a matrix metalloproteinase inhibitor on aphthous ulcers. [2009.02]

Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial. [2009.02]

Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study. [2009.01]

Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. [2008.12]

Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options. [2008.12]

The comparison of the effect of endodontic irrigation on cell adherence to root canal dentin. [2008.12]

The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus. [2008.12]

The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific. [2008.11]

Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. [2008.10]

A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease. [2008.07]

Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitis. [2008.04]

Residual antibacterial activity of chlorhexidine and MTAD in human root dentin in vitro. [2008.03]

Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease? [2008.01]

Combining host modulation and topical antimicrobial therapy in the management of moderate to severe periodontitis: a randomized multicenter trial. [2008.01]

Efficacy of Pradofloxacin in Cats with Feline Upper Respiratory Tract Disease due to Chlamydophila felis or Mycoplasma Infections. [2008.01]

Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia - a controlled clinical trial. [2007.10.11]

Levamisole inhibits sequestration of infected red blood cells in patients with falciparum malaria. [2007.08.01]

Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers. [2007.06]

Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. [2007.03]

Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy. [2007.02]

Comparison of the antimicrobial efficacy of 1.3% NaOCl/BioPure MTAD to 5.25% NaOCl/15% EDTA for root canal irrigation. [2007.01]

Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study. [2007.01]

Effect of non-surgical periodontal therapy on patients with type 2 diabetes mellitus. [2007]

Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis. [2006.11]

Reduction in antimicrobial substantivity of MTAD after initial sodium hypochlorite irrigation. [2006.10]

Failure of imidocarb dipropionate to clear experimentally induced Ehrlichia canis infection in dogs. [2006.07]

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. [2006.05]

Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. [2006.04]

Summary measures were a useful alternative for analyzing therapeutic clinical trial data. [2006.04]

Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. [2006.03]

Other research related to Oracea (Doxycycline)

Subantimicrobial-Dose Doxycycline Modulates Gingival Crevicular Fluid Biomarkers of Periodontitis in Postmenopausal Osteopenic Women. [2008.08]

Efficacy of a New Therapeutic Regimen Versus Two Routinely Prescribed Treatments for Eradication of Helicobacter Pylori: A Randomized, Double-Blind Study of Doxycycline, Co-Amoxiclav, and Omeprazole in Iranian Patients. [2008.07.02]

Update on rosacea and anti-inflammatory-dose doxycycline. [2007.01]

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009